APP and Alzheimer disease: They inhibit AD-related neuronal cell death in vitro5,7, and the transgenic overexpression of the mouse CLSP-1 gene protects against synaptic loss and memory loss in AD model mice, APPswe/PS1dE9 double transgenic mice (APP/PS1 mice), in an amyloid β (Aβ)-independent fashion8.